Tagged: nyse mkt

Reg A+ Issuer Adomani Trades Higher Following Mini-IPO Crowdfunding Offer

Last week there were two companies that raised money crowdfunding under Reg A+ and soon followed by trading on a public exchange. Myomo (NYSE:MYO), raised capital on Banq, and then listed on NYSE MKT. The shares have since traded to a high of about $23 /… Read More

Reg A+ Issuer MyomoTrades Up Following Listing on NYSE MKT

It has been one week since Myomo (NYSE:MYO) became the first Reg A+ issuer to successfully crowdfund and then list on NYSE MKT.  But since listing on the public exchange, Myomo has moved in the right direction.  The shares have rocketed from an issue price of… Read More

Is Reg A+ Crowdfunding Quickly Coming of Age?

Next week two smaller companies intend on listing their shares on a public exchange. What is interesting about this fact is that each of these companies used Regulation A or Reg A+ to facilitate this “mini-IPO” type offer. Created by Title IV of the JOBS… Read More

Myomo Will Become First Reg A+ Issuer to Trade on NYSE MKT

Myomo, a medical robotics company that has developed powered brace to support a weak arm, will become the first Regulation A (Reg A+) issuer to immediately go from crowdfunding to actively trading on an exchange. Myomo will begin trading on the New York Stock Exchange… Read More

Finish Line: Will Myomo Raise Enough Under Reg A+ to List on NYSE MKT?

We last wrote about Myomo, a commercial stage medical robots company (kind of like the Bionic Man), in March. Myomo was in the process of using Reg A+ to raise growth capital. Under the exemption, Myomo was seeking $15 million using Banq, a crowdfunding platform… Read More

Where to List Your Shares? OTC Markets Says it Offers All the Benefits of NYSE MKT at Half the Cost

The advent of new securities exemptions has created opportunity for various sectors of finance. Beyond the fact that issuing companies now have new alternatives for raising capital, and a broader group of investors may gain access to early stage companies, there is a question of… Read More